All Stories

  1. Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
  2. 'Liberation procedure' for treatment of venous stenoses (CCSVI) in the brain of MS sufferers
  3. Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients
  4. Persistent vegetative state: an ethical reappraisal
  5. Natalizumab for relapsing remitting multiple sclerosis
  6. Understanding information on clinical trials by persons with Alzheimer’s dementia. A pilot study
  7. Natalizumab for relapsing remitting multiple sclerosis
  8. Participation in medical decision-making: Attitudes of Italians with multiple sclerosis
  9. Amantadine for fatigue in multiple sclerosis
  10. Development of an ELISA Test for Determination of the Urinary Trypsin Inhibitor: Analytical Performance and Applications
  11. Corrigendum to “Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial” [J. Neurol. Sci. 222 (2004) 99–104]
  12. Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial
  13. Aminopyridines for symptomatic treatment in multiple sclerosis
  14. Information and Competency for Consent to Pharmacologic Clinical Trials in Alzheimer Disease: An Empirical Analysis in Patients and Family Caregivers
  15. Lack of Chlamydia infection of the central nervous system in multiple sclerosis
  16. Lack ofChlamydiainfection of the central nervous system in multiple sclerosis
  17. Cytochemistry of Intraplatelet Ca++ Spots as a Peripheral Marker of Age‐related Brain Impairment
  18. Topographical Disorientation Consequent to Amnesia of Spatial Location in A Patient with Right Parahippocampal Damage
  19. EEG spectral analysis in Alzheimer's disease and different degenerative dementias
  20. Hippocampus and Parahippocampal Gyrus Linear Measurements Based on Magnetic Resonance in Alzheimer’s Disease
  21. EEG power spectrum typical of vascular dementia in a subgroup of Alzheimer patients
  22. An EEG power index (eyes open vs. eyes closed) to differentiate Alzheimer's from vascular dementia and healthy ageing